ArticleCancers2020
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma.
Abstract read
In one paragraph
Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Role of radiomics as a predictor of disease recurrence in ovarian cancer: a systematic review.Abdominal radiology (New York) · 2024Pooled it
- Radiogenomic landscape of the hallmarks of cancer.Biomarker research · 2026Review
- Temporal-spatial evolution of tumor habitat analysis: a bibliometric study on research hotspots and trends in medical imaging (2014-2025).Translational cancer research · 2026Article
- Role of Imaging Techniques in Ovarian Cancer Diagnosis: Current Approaches and Future Directions.Cancers · 2026Review
- Applications of artificial intelligence and machine learning models in the prognosis and diagnosis of ovarian cancer.Frontiers in oncology · 2026Review
- Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Review
- Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools.Molecular therapy. Oncology · 2025Review
- Artificial intelligence radiomics in the diagnosis, treatment, and prognosis of gynecological cancer: a literature review.Translational cancer research · 2025Review
- Article
- Radiology and multi-scale data integration for precision oncology.NPJ precision oncology · 2024Review
- Survival time prediction in patients with high-grade serous ovarian cancer based onBMC cancer · 2024Article
- Clinical Efficacy and Mechanism of Vitamin D2 in Treating Hashimoto's Thyroiditis.Journal of inflammation research · 2024Article
- Incorporating genotype information in a precise prediction model for platinum sensitivity in epithelial ovarian cancer.Frontiers in oncology · 2024Article
- Radiomics in the evaluation of ovarian masses - a systematic review.Insights into imaging · 2023Article
- Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers.European radiology experimental · 2023Review
- Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram.European radiology · 2023Article
- A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility.Insights into imaging · 2023Review
- Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives.Healthcare (Basel, Switzerland) · 2023Review
- Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors.Seminars in immunopathology · 2023Review
- Virtual biopsy in abdominal pathology: where do we stand?BJR open · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Harini VeeraraghavanDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Herbert Alberto VargasDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Alejandro Jimenez-SanchezCancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Center, Cambridge, Cambridgeshire CB2 0RE, UK.
Maura MiccoRadioterapia Oncologica ed Ematologica, Dipartimento Diagnostica per Immagini, Area Diagnostica per Immagini, Radiologica Diagnostica e Interventistica Generale, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.ORCID 0000-0002-5790-6327
Eralda MemaColumbia University Medical Center, New York, NY 10032, USA.
Yulia LakhmanDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Mireia Crispin-OrtuzarCancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Center, Cambridge, Cambridgeshire CB2 0RE, UK.ORCID 0000-0002-4351-3709
Erich P HuangNational Cancer Institute, Rockville, MD 20850, USA.
Douglas A LevineLaura and Issac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016, USA.
Rachel N GrishamDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-8631-9324
Nadeem Abu-RustumDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Joseph O DeasyDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Alexandra SnyderDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Martin L MillerCancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Center, Cambridge, Cambridgeshire CB2 0RE, UK.
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Center, Cambridge, Cambridgeshire CB2 0RE, UK.
Evis SalaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-5518-9360
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MCancer Research UK 15601Cancer Research UK 21141Cancer Research UK 22905NCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
chemotherapy response prognosticationcomputed tomographyhigh grade serous ovarian cancerintra-site and inter-site radiomic heterogeneitymachine learningradiomics
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.